TRAIL-secreting mesenchymal stem cells promote apoptosis in heat-shock-treated liver cancer cells and inhibit tumor growth in nude mice
暂无分享,去创建一个
P. Bie | Q. Deng | K. Ma | Z. Zhang | L. Shuai | H. Zou | X. Li | Y. Wang | X. Feng | Q. Xiong | N. Liu | J. Lai | T. Li | C. Fu | X. Feng | X. Feng | T. Li
[1] Zheng-Yu Lin,et al. Treatment of hepatocellular carcinoma adjacent to large blood vessels using 1.5T MRI-guided percutaneous radiofrequency ablation combined with iodine-125 radioactive seed implantation. , 2012, European journal of radiology.
[2] S. Libutti,et al. Phase I study of heat-deployed liposomal doxorubicin during radiofrequency ablation for hepatic malignancies. , 2012, Journal of vascular and interventional radiology : JVIR.
[3] P. Robbins,et al. Preclinical studies for pharmacokinetics and biodistribution of Ad-stTRAIL, an adenovirus delivering secretable trimeric TRAIL for gene therapy , 2011, Experimental & Molecular Medicine.
[4] Hiroyuki Tomita,et al. Bone marrow-derived myofibroblasts contribute to the mesenchymal stem cell niche and promote tumor growth. , 2011, Cancer cell.
[5] C. Mathers,et al. Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008 , 2010, International journal of cancer.
[6] Yong Zeng,et al. A Randomized Trial Comparing Radiofrequency Ablation and Surgical Resection for HCC Conforming to the Milan Criteria , 2010, Annals of surgery.
[7] G. Rossi,et al. Adipose-derived mesenchymal stem cells as stable source of tumor necrosis factor-related apoptosis-inducing ligand delivery for cancer therapy. , 2010, Cancer research.
[8] O. Podhajcer,et al. Mesenchymal stem cells as therapeutic tools and gene carriers in liver fibrosis and hepatocellular carcinoma , 2010, Gene Therapy.
[9] P. V. van Diest,et al. Accelerated Perinecrotic Outgrowth of Colorectal Liver Metastases Following Radiofrequency Ablation is a Hypoxia-Driven Phenomenon , 2009, Annals of surgery.
[10] H. Bear,et al. Radiofrequency thermal ablation of breast tumors combined with intralesional administration of IL-7 and IL-15 augments anti-tumor immune responses and inhibits tumor development and metastasis , 2009, Breast Cancer Research and Treatment.
[11] Yan Zhang,et al. Combined endostatin and TRAIL gene transfer suppresses human hepatocellular carcinoma growth and angiogenesis in nude mice , 2009, Cancer biology & therapy.
[12] K. Song,et al. Possible Novel Therapy for Malignant Gliomas with Secretable Trimeric TRAIL , 2009, PloS one.
[13] G. Shore,et al. Bcl-2 Proteins and Apoptosis: Choose Your Partner , 2008, Cell.
[14] Y. Sung,et al. Gene therapy using TRAIL-secreting human umbilical cord blood-derived mesenchymal stem cells against intracranial glioma. , 2008, Cancer research.
[15] K. Mukherjea,et al. Histological vis – a – vis biochemical assessment on the toxic level and antineoplastic efficacy of a synthetic drug Pt – ATP on experimental animal models , 2008, Journal of experimental & clinical cancer research : CR.
[16] P. Secchiero,et al. Tumor Necrosis Factor‐Related Apoptosis‐Inducing Ligand Promotes Migration of Human Bone Marrow Multipotent Stromal Cells , 2008, Stem cells.
[17] A. Carrato,et al. Does chemotherapy prior to liver resection increase the potential for cure in patients with metastatic colorectal cancer? A report from the European Colorectal Metastases Treatment Group. , 2007, European journal of cancer.
[18] P. Robbins,et al. Cancer gene therapy using a novel secretable trimeric TRAIL , 2006, Gene Therapy.
[19] J. Haaga,et al. Combined tumor therapy by using radiofrequency ablation and 5-FU-laden polymer implants: evaluation in rats and rabbits. , 2005, Radiology.
[20] P. Flecknell,et al. Study of apoptosis and heat shock protein (HSP) expression in hepatocytes following radiofrequency ablation (RFA). , 2005, The Journal of surgical research.
[21] J. Luk,et al. Hepatic potential of bone marrow stromal cells: development of in vitro co-culture and intra-portal transplantation models. , 2005, Journal of immunological methods.
[22] Guy Marchal,et al. Local Recurrence After Hepatic Radiofrequency Coagulation: Multivariate Meta-Analysis and Review of Contributing Factors , 2005, Annals of surgery.
[23] Z. Zhao,et al. Rat bone marrow mesenchymal stem cells differentiate into hepatocytes in vitro. , 2005, World journal of gastroenterology.
[24] D. Seol,et al. The secretable form of trimeric TRAIL, a potent inducer of apoptosis. , 2004, Biochemical and biophysical research communications.
[25] D. Rockey,et al. Cell and molecular regulation of endothelin-1 production during hepatic wound healing. , 2003, Molecular biology of the cell.
[26] Thomas D. Schmittgen,et al. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. , 2001, Methods.
[27] Z. Wang,et al. Tumoricidal activity of a novel anti-human DR5 monoclonal antibody without hepatocyte cytotoxicity , 2001, Nature Medicine.
[28] I. Bechmann,et al. Human brain-cell death induced by tumour-necrosis-factor-related apoptosis-inducing ligand (TRAIL) , 2000, The Lancet.
[29] K. Shiraki,et al. Chemotherapeutic Agents Augment TRAIL‐Induced Apoptosis in Human Hepatocellular Carcinoma Cell Lines , 2000, Hepatology.
[30] F. Ranelletti,et al. Flavonoids apigenin and quercetin inhibit melanoma growth and metastatic potential , 2000, International journal of cancer.
[31] S. Strom,et al. Apoptosis induced in normal human hepatocytes by tumor necrosis factor-related apoptosis-inducing ligand , 2000, Nature Medicine.
[32] S. Marsters,et al. Induction of Apoptosis by Apo-2 Ligand, a New Member of the Tumor Necrosis Factor Cytokine Family* , 1996, The Journal of Biological Chemistry.
[33] A. Jemal,et al. Global Cancer Statistics , 2011 .
[34] N. Borys,et al. Lyso-thermosensitive liposomal doxorubicin: a novel approach to enhance efficacy of thermal ablation of liver cancer. , 2009, Expert opinion on pharmacotherapy.
[35] Yong J. Lee,et al. Effect of hyperthermia and chemotherapeutic agents on TRAIL‐induced cell death in human colon cancer cells , 2008, Journal of cellular biochemistry.
[36] D. Prockop,et al. Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statement. , 2006, Cytotherapy.
[37] A. Jemal,et al. Global cancer statistics , 2011, CA: a cancer journal for clinicians.